Sex differences in the clinical manifestations related to dependence behaviors in medication-overuse headache

Objective The present study aimed to compare sex differences in the clinical manifestations related to dependence behaviors in medication-overuse headache (MOH). Methods Consecutive patients with newly diagnosed chronic migraine (CM) with and without MOH based on the Third Edition of International C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of headache and pain 2023-11, Vol.24 (1), p.145-145, Article 145
Hauptverfasser: Wang, Yen-Feng, Tzeng, Yi-Shiang, Yu, Chia-Chun, Ling, Yu-Hsiang, Chen, Shih-Pin, Lai, Kuan-Lin, Chen, Wei-Ta, Wang, Shuu-Jiun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective The present study aimed to compare sex differences in the clinical manifestations related to dependence behaviors in medication-overuse headache (MOH). Methods Consecutive patients with newly diagnosed chronic migraine (CM) with and without MOH based on the Third Edition of International Classification of Headache Disorders (ICHD-3) were enrolled prospectively from the headache clinic of a tertiary medical center. Demographics and clinical profiles were collected by using a questionnaire, which included current use of tobacco, alcohol, and caffeinated beverages, the Leeds Dependence Questionnaire (LDQ), the Severity of Dependence Scale (SDS), the Headache Impact Test-6 (HIT-6), and the Pittsburgh Sleep Quality Index (PSQI). Results In total, 1419 CM patients (1135F/284 M, mean age 41.7 ± 13.9 years) were recruited, including 799 with MOH (640F/159 M, mean age 42.5 ± 13.2 years) (56.3%). Smoking was associated with an increased risk for MOH in men (odds ratio [OR] = 3.60 [95% confidence interval = 1.73–7.50], p  = 0.001), but not in women (OR = 1.34 [0.88–2.04], p  = 0.171) ( p  = 0.021 for interaction). Hypnotic use ≥ 3 days/week was a risk factor for MOH (OR = 2.55 [95% confidence interval = 2.00–3.24], p  
ISSN:1129-2377
1129-2369
1129-2377
DOI:10.1186/s10194-023-01685-z